Zhejiang Sukean Pharmaceutical

Zhejiang Sukean Pharmaceutical is a China-based pharmaceutical company and a subsidiary of Fosun Pharma, primarily focused on the production and commercialization of specialized therapeutics. The company is best known for its involvement with Avatrombopag maleate (marketed under the brand name Sukean), a second-generation thrombopoietin receptor agonist used to treat thrombocytopenia in patients with chronic liver disease or immune thrombocytopenia. Operating out of Haining, Zhejiang, the company maintains modern manufacturing facilities that adhere to international quality standards. Its business model integrates research, development, and large-scale production to support Fosun Pharma's broader hematology and oncology portfolio. The establishment of the company represents a key part of Fosun Pharma's strategy to localize the production of innovative drugs acquired through international partnerships.